News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘StemCellTransplant’ clear

  • A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases.

Tags: BasicResearch, StemCellTransplant

  • Dana-Farber Cancer Institute scientists provide the first statistically-based guidelines for determining whether stem cell transplant is appropriate for patients older than 60 with myelodysplastic syndromes (MDS)

Tags: StemCellTransplant, Leukemia

  • A Dana-Farber study challenges the hypothesis that "cancer stem cells" — a small number of self-renewing cells within a tumor — are responsible for breast cancer progression and recurrence, and that wiping out these cells alone could cure the disease.

Tags: BreastCancer, StemCellTransplant

  • An analysis of two dozen clinical studies finds most adults with poor-risk and intermediate-risk acute myeloid leukemia benefit from allogeneic stem cell transplants.

Tags: BasicResearch, StemCellTransplant, Leukemia

  • Researchers report that patients with high-risk acute AML who received a cancer vaccine after a stem cell transplant had few complications and mounted a strong immune system attack on the disease.

Tags: StemCellTransplant, Leukemia

  • The pre-cancerous blood disorder myelodsysplastic syndrome (MDS) affects between 35,000 and 55,000 people in the United States. Dana-Farber's David Steensma, MD, discusses MDS and its treatment.

Tags: StemCellTransplant, Leukemia

  • Dana-Farber researchers find adding bortezomib to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for some patients.

Tags: GraftVersusHost, StemCellTransplant

  • A common, sometimes severe viral disease in patients receiving a transplant of donated stem cells can be prevented by a new drug given shortly after transplant, according to a study led by Dana-Farber Cancer Institute and Brigham and Women's Hospital researchers.

Tags: StemCellTransplant

  • Dana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.

Tags: BasicResearch, StemCellTransplant, Leukemia

  • Almost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.

Tags: ChildhoodCancer, StemCellTransplant

Showing 1-10 of 18 items